Search Results - "Kawasaki, Mamiko"

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial by Nishikawa, Tadaaki, Hasegawa, Kosei, Matsumoto, Koji, Mori, Masahiko, Hirashima, Yasuyuki, Takehara, Kazuhiro, Ariyoshi, Kazuya, Kato, Tomoyasu, Yagishita, Shigehiro, Hamada, Akinobu, Kawasaki, Mamiko, Kawashima, Satoshi, Tomatsuri, Sawako, Nagasaka, Yukari, Yoshida, Hiroshi, Machida, Ryunosuke, Hirakawa, Akihiro, Nakamura, Kenichi, Yonemori, Kan

“…To investigate the efficacy and safety of trastuzumab deruxtecan, an antibody-drug conjugate targeting human epidermal growth factor receptor 2 (HER2) with a…”
Get full text

Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial by Sato, Jun, Satouchi, Miyako, Itoh, Shoichi, Okuma, Yusuke, Niho, Seiji, Mizugaki, Hidenori, Murakami, Haruyasu, Fujisaka, Yasuhito, Kozuki, Toshiyuki, Nakamura, Kenichi, Nagasaka, Yukari, Kawasaki, Mamiko, Yamada, Tomoaki, Machida, Ryunosuke, Kuchiba, Aya, Ohe, Yuichiro, Yamamoto, Noboru

“…Thymic carcinoma is a rare malignant disease and standard treatment for advanced or metastatic thymic carcinoma previously treated with platinum-based…”
Get full text

Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510) by Nishikawa, Tadaaki, Kakunaga, Shigeki, Tamura, Kenji, Ando, Masashi, Ozaki, Toshifumi, Kawai, Akira, Ueda, Takafumi, Kawasaki, Mamiko, Tomatsuri, Sawako, Okamura, Nobuko, Kamikura, Masahisa, Hamada, Akinobu, Yoshida, Akihiko, Hirakawa, Akihiro, Shibata, Taro, Nakamura, Kenichi, Yonemori, Kan

“…ABSTRACT Background Clear cell sarcoma (CCS) and alveolar soft part sarcoma (ASPS) are rare, and standard systemic therapy is not established except for…”
Get full text

A phase II study of lenvatinib in patients with metastatic colorectal cancer refractory to standard chemotherapy: LEMON study (NCCH1503) by Shoji, Hirokazu, Iwasa, Satoru, Kuchiba, Aya, Ogawa, Gakuto, Kawasaki, Mamiko, Nakamura, Kenichi, Mori, Mikio, Honma, Yoshitaka, Takashima, Atsuo, Kato, Ken, Boku, Narikazu, Okita, Natsuko, Yamada, Yasuhide

“…Abstract only 3538 Background: Although regorafenib significantly improved overall survival compared with placebo for patients with metastatic colorectal…”
Get full text

Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503) by Iwasa, Satoru, Okita, Natsuko, Kuchiba, Aya, Ogawa, Gakuto, Kawasaki, Mamiko, Nakamura, Kenichi, Shoji, Hirokazu, Honma, Yoshitaka, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Boku, Narikazu, Yamada, Yasuhide

“…BackgroundLenvatinib inhibits tyrosine kinases, including vascular endothelial growth factor (VEGF) receptor, fibroblast growth factor receptor,…”
Get full text

Down-regulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats by MASUBUCHI, Yasuhiro, KAWASAKI, Mamiko, HORIE, Toshiharu

“…Hepatic drug metabolism is impaired in experimental animals and humans with renal diseases. An anticancer drug, cisplatin induces acute renal failure (ARF) in…”
Get full text